Other substances

Ivermectin B1b

Ivermectin drug minor component.

Phase of research

Potential treatment - theoretical effect

How it helps

Antiviral

Drug status

Used to treat other disease

1
 Supporting references
0
 Contradictory references
0
 AI-suggested references
0
 Clinical trials

General information

Ivermectin B1b on PubCem

 

Structure image - Ivermectin B1b

C[C@H]1CC[C@]2(C[C@@H]3C[C@H](O2)C/C=C(/[C@H]([C@H](/C=C/C=C/4\CO[C@H]5[C@@]4([C@@H](C=C([C@H]5O)C)C(=O)O3)O)C)O[C@H]6C[C@@H]([C@H]([C@@H](O6)C)O[C@H]7C[C@@H]([C@H]([C@@H](O7)C)O)OC)OC)\C)O[C@@H]1C(C)C

Supporting references

Link Tested on Impact factor Notes Publication date
Step toward repurposing drug discovery for COVID‐19 therapeutics through in silico approach
Spike protein 3CLpro PapainLpro RdRpol nsp3 nsp16 nsp9 nsp10 nsp4 Helicase (nsp19) Small molecule In silico 		in silico 1.90

Predicted to bind SARS-CoV-2 3C-like protease, nsp9, and nsp16-nsp10 proteins.

 Nov/10/2020
Export (.csv)